Exec Chat: Medtronic CMO On How COVID-19 Has Changed The Company – And Where It’s Headed
In an exclusive Q&A with Medtech Insight, Medtronic’s Robert Kowal talks about how COVID-19 has pushed the company to focus on remote capabilities for their cardiac devices, permanently changed its corporate culture, and more.
You may also be interested in...
It is time for In Vivo's 13th annual Deals of the Year contest. We've selected 15 nominees in three categories – Top Alliance, Top Financing and Top M&A – and you get to pick the winners.
The US agency’s device center on 26 October published its A and B lists of guidance documents it will prioritize in fiscal year 2022, including drafting guidances to transition emergency use authorized products to full marketing status, and finalizing a clinical decision support software guidance that’s been four years in the making.
The European medical devices notified bodies association says a proposed rule published earlier in the year risks forcing manufacturers, regulators and notified bodies to duplicate their work.